(Q43719534)

English

Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial--the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial

scientific article published in August 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial--the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

circulatory system

1 reference

based on heuristic

inferred from title

author name string

D Ponec

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

D Irwin

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

W D Haire

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

P A Hill

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

X Li

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

E R McCluskey

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

COOL Investigators

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

1 August 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Journal of Vascular and Interventional Radiology

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

951-955

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Complications and management of implanted venous access catheters

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961575-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The timing and sequence of multiple device-related complications in patients with long-term indwelling Groshong catheters

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961575-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Restoring patency of occluded central venous catheters

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961575-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Obstructed central venous catheters. Restoring function with a 12-hour infusion of low-dose urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961575-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Are clinical signs accurate indicators of the cause of central venous catheter occlusion?

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961575-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Investigational use of tissue plasminogen activator (t-PA) for occluded central venous catheters.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961575-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity and dosage of alteplase dilution for clearing occlusions of venous-access devices

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961575-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of cryopreserved recombinant alteplase for declotting thrombosed central catheters

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961575-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombolysis of Blocked Hemodialysis Catheter Using Recombinant Tissue-Type Plasminogen Activator

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961575-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of tissue plasminogen activator for reopening of clotted dialysis catheters

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961575-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant tissue plasminogen activator is a useful alternative to heparin in priming quinton permcath

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961575-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961575-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1051-0443(07)61575-9

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43719534&oldid=2102816163"